Marcos Petti

1.4k total citations
16 papers, 1.1k citations indexed

About

Marcos Petti is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Marcos Petti has authored 16 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 7 papers in Public Health, Environmental and Occupational Health and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Marcos Petti's work include Trypanosoma species research and implications (13 papers), Research on Leishmaniasis Studies (7 papers) and Viral Infections and Immunology Research (5 papers). Marcos Petti is often cited by papers focused on Trypanosoma species research and implications (13 papers), Research on Leishmaniasis Studies (7 papers) and Viral Infections and Immunology Research (5 papers). Marcos Petti collaborates with scholars based in Argentina and United States. Marcos Petti's co-authors include Rodolfo Viotti, Graciela Bertocchi, M Alvarez, Carlos Vigliano, Alejandro Armenti, Bruno Lococo, Bruno Lococo, Miriam Postan, Susana A. Laucella and Rick L. Tarleton and has published in prestigious journals such as Annals of Internal Medicine, Frontiers in Immunology and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Marcos Petti

16 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marcos Petti Argentina 12 991 726 267 181 156 16 1.1k
Elizabeth Posada Spain 19 1.1k 1.1× 717 1.0× 193 0.7× 167 0.9× 231 1.5× 27 1.2k
Antônio José Cordeiro Mattos Brazil 5 834 0.8× 594 0.8× 230 0.9× 186 1.0× 126 0.8× 6 913
Graciela Bertocchi Argentina 18 1.3k 1.4× 1.0k 1.4× 358 1.3× 218 1.2× 246 1.6× 31 1.4k
Bruno Lococo Argentina 9 927 0.9× 751 1.0× 227 0.9× 131 0.7× 181 1.2× 13 960
Alejandro Armenti Argentina 16 1.3k 1.4× 1.0k 1.4× 358 1.3× 235 1.3× 230 1.5× 25 1.4k
Patricia Paglini‐Oliva Argentina 18 564 0.6× 461 0.6× 210 0.8× 116 0.6× 80 0.5× 45 689
A. Rassi Brazil 6 690 0.7× 351 0.5× 68 0.3× 299 1.7× 105 0.7× 10 825
Guillermo Moscatelli Argentina 14 527 0.5× 357 0.5× 153 0.6× 57 0.3× 78 0.5× 44 633
Samanta Moroni Argentina 13 452 0.5× 302 0.4× 131 0.5× 51 0.3× 61 0.4× 33 539
Griselda Ballering Argentina 13 417 0.4× 273 0.4× 95 0.4× 54 0.3× 65 0.4× 27 464

Countries citing papers authored by Marcos Petti

Since Specialization
Citations

This map shows the geographic impact of Marcos Petti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcos Petti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcos Petti more than expected).

Fields of papers citing papers by Marcos Petti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcos Petti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcos Petti. The network helps show where Marcos Petti may publish in the future.

Co-authorship network of co-authors of Marcos Petti

This figure shows the co-authorship network connecting the top 25 collaborators of Marcos Petti. A scholar is included among the top collaborators of Marcos Petti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcos Petti. Marcos Petti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Bertocchi, Graciela, Carlos Vigliano, Bruno Lococo, Marcos Petti, & Rodolfo Viotti. (2013). Clinical characteristics and outcome of 107 adult patients with chronic Chagas disease and parasitological cure criteria. Transactions of the Royal Society of Tropical Medicine and Hygiene. 107(6). 372–376. 30 indexed citations
2.
Alvarez, M, Carlos Vigliano, Bruno Lococo, et al.. (2012). Seronegative conversion after incomplete benznidazole treatment in chronic Chagas disease. Transactions of the Royal Society of Tropical Medicine and Hygiene. 106(10). 636–638. 26 indexed citations
3.
Pérez‐Mazliah, Damián, M Alvarez, Gretchen Cooley, et al.. (2012). Sequential combined treatment with allopurinol and benznidazole in the chronic phase of Trypanosoma cruzi infection: a pilot study. Journal of Antimicrobial Chemotherapy. 68(2). 424–437. 42 indexed citations
4.
Pérez‐Mazliah, Damián, María C. Albareda, M Alvarez, et al.. (2012). Allopurinol reduces antigen-specific and polyclonal activation of human T cells. Frontiers in Immunology. 3. 295–295. 17 indexed citations
5.
Viotti, Rodolfo, Carlos Vigliano, M Alvarez, et al.. (2011). Impact of Aetiological Treatment on Conventional and Multiplex Serology in Chronic Chagas Disease. PLoS neglected tropical diseases. 5(9). e1314–e1314. 81 indexed citations
6.
Viotti, Rodolfo, Carlos Vigliano, M Alvarez, et al.. (2009). The Impact of Socioeconomic Conditions on Chronic Chagas Disease Progression. Revista Española de Cardiología (English Edition). 62(11). 1224–1232. 24 indexed citations
7.
Viotti, Rodolfo, Carlos Vigliano, Bruno Lococo, et al.. (2009). Side effects of benznidazole as treatment in chronic Chagas disease: fears and realities. Expert Review of Anti-infective Therapy. 7(2). 157–163. 252 indexed citations
8.
Viotti, Rodolfo, Carlos Vigliano, M Alvarez, et al.. (2009). El impacto de las condiciones socioeconómicas en la evolución de la enfermedad de Chagas crónica. Revista Española de Cardiología. 62(11). 1224–1232. 27 indexed citations
9.
Bertocchi, Graciela, M Alvarez, Alejandro Armenti, et al.. (2008). Evaluación inmunológica del tratamiento con benznidazol en la enfermedad de Chagas crónica. Redalyc (Universidad Autónoma del Estado de México). 76(4). 260–265. 3 indexed citations
10.
Bertocchi, Graciela, M Alvarez, Alejandro Armenti, et al.. (2008). Immunological Assessment of Benznidazole Therapy in Chronic Chagas Disease. 1 indexed citations
11.
Petti, Marcos, Rodolfo Viotti, Alejandro Armenti, et al.. (2008). Predictors of Heart Failure in Chronic Chagasic Cardiomyopathy With Asymptomatic Left Ventricular Dysfunction. Revista Española de Cardiología (English Edition). 61(2). 116–122. 8 indexed citations
12.
Petti, Marcos, Rodolfo Viotti, Alejandro Armenti, et al.. (2008). Predictores de insuficiencia cardiaca en la miocardiopatía chagásica crónica con disfunción asintomática del ventrículo izquierdo. Revista Española de Cardiología. 61(2). 116–122. 7 indexed citations
13.
Viotti, Rodolfo, Carlos Vigliano, Bruno Lococo, et al.. (2006). Long-Term Cardiac Outcomes of Treating Chronic Chagas Disease with Benznidazole versus No Treatment. Annals of Internal Medicine. 144(10). 724–734. 443 indexed citations
14.
Viotti, Rodolfo, Carlos Vigliano, Bruno Lococo, et al.. (2005). Clinical Predictors of Chronic Chagasic Myocarditis Progression. Revista Española de Cardiología (English Edition). 58(9). 1037–1044. 38 indexed citations
15.
Viotti, Rodolfo, Carlos Vigliano, Bruno Lococo, et al.. (2005). Indicadores clínicos de progresión de la miocarditis chagásica crónica. Revista Española de Cardiología. 58(9). 1037–1044. 49 indexed citations
16.
Petti, Marcos, et al.. (1953). MOTILITY OF THE SMALL INTESTINE DURING EMOTIONAL REACTIONS. Annals of Internal Medicine. 38(1). 38–52. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026